Clinical Trials Browser

Ependymoma, Medulloblastoma, Recurrence

NCT07263438 2026-02-13

Phenix

Phase 2 Recruiting

59 enrolled

CNS

Glioblastoma, Recurrence

NCT05797246 2026-01-26

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Phase 2 Active not recruiting

21 enrolled

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

Clinical Trials

MEMMAT

Phenix

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

TROY

A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

NALIRIBVRG

BELLA

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

BOLD

Pembrolizumab +/- Bevacizumab for Recurrent GBM

ANG1005 in Patients With Recurrent High-Grade Glioma

ReACT

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

RADBEV

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

AMG 102 and Avastin for Recurrent Malignant Glioma

Bevacizumab for Recurrent Malignant Glioma

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)